Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of 389.52 million. The enterprise value is 470.29 million.
| Market Cap | 389.52M |
| Enterprise Value | 470.29M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.43 billion shares outstanding. The number of shares has increased by 10.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.43B |
| Shares Change (YoY) | +10.99% |
| Shares Change (QoQ) | +3.89% |
| Owned by Insiders (%) | 7.57% |
| Owned by Institutions (%) | 0.05% |
| Float | 1.32B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 281.85 |
| PB Ratio | -4.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.10 |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.16 |
| Interest Coverage | -8.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -152.28% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 160.08% |
| Revenue Per Employee | 55,280 |
| Profits Per Employee | -3.41M |
| Employee Count | 25 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.87% in the last 52 weeks. The beta is -0.82, so NWBO's price volatility has been lower than the market average.
| Beta (5Y) | -0.82 |
| 52-Week Price Change | -39.87% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 49.23 |
| Average Volume (20 Days) | 6,527,130 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.64 |
Income Statement
In the last 12 months, NWBO had revenue of 1.38 million and -85.19 million in losses. Loss per share was -0.07.
| Revenue | 1.38M |
| Gross Profit | -33.51M |
| Operating Income | -66.51M |
| Pretax Income | -83.78M |
| Net Income | -85.19M |
| EBITDA | -64.76M |
| EBIT | -66.51M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 2.18 million in cash and 67.44 million in debt, giving a net cash position of -65.27 million or -0.05 per share.
| Cash & Cash Equivalents | 2.18M |
| Total Debt | 67.44M |
| Net Cash | -65.27M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | -78.98M |
| Book Value Per Share | -0.07 |
| Working Capital | -64.21M |
Cash Flow
In the last 12 months, operating cash flow was -57.02 million and capital expenditures -1.01 million, giving a free cash flow of -58.03 million.
| Operating Cash Flow | -57.02M |
| Capital Expenditures | -1.01M |
| Free Cash Flow | -58.03M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,812.45% |
| Pretax Margin | -6,062.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.99% |
| Shareholder Yield | -10.99% |
| Earnings Yield | -21.87% |
| FCF Yield | -14.90% |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |
Scores
NWBO has an Altman Z-Score of -83.74. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -83.74 |
| Piotroski F-Score | n/a |